# Evaluate Efficacy and Safety of ChloraSolv When Treating Pressure Ulcers in Need of Debridement

> **NCT05547191** · NA · TERMINATED · sponsor: **RLS Global** · enrollment: 5 (actual)

## Conditions studied

- Pressure Ulcer

## Interventions

- **DEVICE:** ChloraSolv

## Key facts

- **NCT ID:** NCT05547191
- **Lead sponsor:** RLS Global
- **Sponsor class:** INDUSTRY
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2023-09-01
- **Primary completion:** 2023-11-20
- **Final completion:** 2023-11-20
- **Target enrollment:** 5 (ACTUAL)
- **Why stopped:** RLS Global in bankruptcy
- **Last updated:** 2023-12-04


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05547191

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05547191, "Evaluate Efficacy and Safety of ChloraSolv When Treating Pressure Ulcers in Need of Debridement". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT05547191. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*